Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

Company Overview

Walgreens Boots Alliance, Inc. is a global leader in pharmacy, health and wellness retail, and pharmaceutical wholesale and distribution. Formed in December 2014 through the merger of Walgreens, a prominent U.S. drugstore chain, and Alliance Boots, a leading international health and beauty retailer and wholesaler, the company combines a comprehensive network of retail pharmacies, e-commerce platforms and wholesale operations. Its core offerings include prescription drugs, over-the-counter medications, health and beauty products, retail general merchandise and specialty pharmacy services.

The company operates under several banners, most notably Walgreens in the United States and Boots in the United Kingdom and Ireland, serving millions of customers each week. In addition to its consumer-facing retail stores, Walgreens Boots Alliance provides wholesale distribution of pharmaceutical and healthcare products to hospitals, clinics and independent pharmacies through its Alliance Healthcare division. The company continues to invest in digital health initiatives, pharmacy care services and supply chain efficiencies to enhance customer experience and support healthcare providers.

Headquartered in Deerfield, Illinois, Walgreens Boots Alliance maintains a presence across North America, Europe, and selected markets in the Middle East, Asia and Latin America. With a history dating back to Boots’ founding in 1849 in Nottingham, England, the combined entity leverages decades of expertise in retail pharmacy and beauty retailing. The company’s retail formats range from neighborhood drugstores to expanded health and wellness destinations, reflecting its commitment to accessible care and personalized consumer experiences.

Under the leadership of Chief Executive Officer Rosalind “Roz” Brewer and Executive Chairman Stefano Pessina, Walgreens Boots Alliance focuses on integrating its global footprint, optimizing its store portfolio and expanding partnerships in healthcare services. The company aims to drive long-term growth by strengthening its pharmacy-led model, enhancing digital engagement and delivering value to patients, customers and stakeholders worldwide.

Key Stats

• Today's Range: $11.98 to $11.98
• 50-Day Range: $11.49 to $12.20
• 52-Week Range: $8.08 to $13.25
• Volume: N/A
• Average Volume: 35.94 million shs
• Market Capitalization: $10.37 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.15
• Consensus Rating: Reduce

Walgreens Boots Alliance Stock Analysis - MarketRank™

Walgreens Boots Alliance scored higher than 47% of companies evaluated by MarketBeat, and ranked 155th out of 220 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Reduce

Consensus Rating

Walgreens Boots Alliance has received a consensus rating of Reduce. The company's average rating score is 1.73, and is based on 1 buy rating, 6 hold ratings, and 4 sell ratings.

Downside Risk

Walgreens Boots Alliance has a consensus price target of $10.15, representing about 15.3% downside from its current price of $11.98.

Amount of Analyst Coverage

Walgreens Boots Alliance has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -8.75%

Earnings Growth

Earnings for Walgreens Boots Alliance are expected to decrease by -8.75% in the coming year, from $1.60 to $1.46 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Walgreens Boots Alliance is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Walgreens Boots Alliance is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Walgreens Boots Alliance has a PEG Ratio of 1.42. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Walgreens Boots Alliance has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.17% of the float of Walgreens Boots Alliance has been sold short.

Short Interest Ratio / Days to Cover

Walgreens Boots Alliance has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Walgreens Boots Alliance has recently decreased by 2.08%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Walgreens Boots Alliance does not currently pay a dividend.

Dividend Growth

Walgreens Boots Alliance does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 2.3 / 5
• Environmental Score: -2.09

Percentage of Shares Shorted

3.17% of the float of Walgreens Boots Alliance has been sold short.

Short Interest Ratio / Days to Cover

Walgreens Boots Alliance has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Walgreens Boots Alliance has recently decreased by 2.08%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.95

News Sentiment

Walgreens Boots Alliance has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Retail/Wholesale companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Walgreens Boots Alliance this week, compared to 19 articles on an average week.

Search Interest

Only 40 people have searched for WBA on MarketBeat in the last 30 days. This is a decrease of -2% compared to the previous 30 days.

MarketBeat Follows

7 people have added Walgreens Boots Alliance to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Walgreens Boots Alliance insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.50% of the stock of Walgreens Boots Alliance is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.59% of the stock of Walgreens Boots Alliance is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

WBA Stock Analysis - Frequently Asked Questions

How have WBA shares performed this year?

Walgreens Boots Alliance's stock was trading at $9.33 at the start of the year. Since then, WBA stock has increased by 28.4% and is now trading at $11.98.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced its quarterly earnings results on Thursday, June, 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. The business's revenue was up 7.2% on a year-over-year basis.

Does Walgreens Boots Alliance have any subsidiaries?

Walgreens Boots Alliance subsidiaries include these companies: Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and more.

Who are Walgreens Boots Alliance's major shareholders?

Top institutional shareholders of Walgreens Boots Alliance include State Street Corp (3.73%), Invesco Ltd. (2.67%), Geode Capital Management LLC (2.22%) and Norges Bank (2.00%). Insiders that own company stock include Stefano Pessina, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Verizon Communications (VZ), Meta Platforms (META), NVIDIA (NVDA), Intel (INTC) and Humana (HUM).

Company Calendar

• Last Earnings: 6/26/2025
• Today: 9/15/2025
• Next Earnings (Estimated): 10/21/2025
• Fiscal Year End: 8/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: RETAIL - DRUG STR
• Sub-Industry: Drug Retail
• Current Symbol: NASDAQ:WBA
• CIK: 1618921
• Web: www.walgreensbootsalliance.com
• Phone: (847) 315-3700
• Fax: 847-914-2804
• Employees: 325,000
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Walgreens Boots Alliance: $10.15
• High Price Target: $14.00
• Low Price Target: $7.00
• Potential Upside/Downside: -15.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.73
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): ($7.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 7.49
• P/E Growth: 1.42
• Net Income: -$8.64 billion
• Net Margins: -4.07%
• Pretax Margin: -3.79%
• Return on Equity: 17.66%
• Return on Assets: 2.22%

Debt

• Debt-to-Equity Ratio: 0.96
• Current Ratio: 0.60
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $147.66 billion
• Price / Sales: 0.07
• Cash Flow: $5.73 per share
• Price / Cash Flow: 2.09
• Book Value: $13.91 per share
• Price / Book: 0.86

Miscellaneous

• Outstanding Shares: 865,560,000
• Free Float: 714,088,000
• Market Cap: $10.37 billion
• Optionable: Optionable
• Beta: 0.80